SkyOak Wealth, LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1800379 SOUTHFIELD, MI

Position in ALNY

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$251,461

-$50,753 QoQ

Shares Held

760

0.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

SkyOak Wealth, LLC holds $870,525 across 4 Biotechnology names. ALNY ranks #3 (28.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CPRX	Catalyst Pharmaceuticals, Inc.	12,232	$302,864
2	NMRA	Neumora Therapeutics, Inc.	150,000	$292,500
3	ALNY	Alnylam Pharmaceuticals, Inc. This page	760	$251,461
4	LCTX	Lineage Cell Therapeutics, Inc.	15,000	$23,700

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$251,461	760	0.0%	Shares	Sole	2026-04-30
2025-12-31	$302,214	760	-10.3%	Shares	Sole	2026-02-05
2025-09-30	$386,232	847	-49.6%	Shares	Sole	2025-10-23
2021-06-30	$284,963	1,681	-1.6%	Shares	Sole	2021-07-19
2021-03-31	$241,152	1,708	-51.8%	Shares	Sole	2021-04-29
2020-12-31	$460,743	3,545	—	Shares	Sole	2021-02-02
No filing history on record for this holder in this stock.